Continuous Renal Replacement Therapy Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, by Modality, by Age Group : Global Opportunity Analysis and Industry Forecast, 2021-2031

Continuous Renal Replacement Therapy Market Research, 2031

The global Continuous Renal Replacement Therapy Market Size was valued at $1.3 billion in 2021, and is projected to reach $2.6 billion by 2031, growing at a CAGR of 7.7% from 2022 to 2031. Continuous renal replacement therapy (CRRT) is a slow and smooth continuous extracorporeal blood purification process. It is usually implemented over 24 hours to several days with gentle removal of fluid and excess uremic toxins. This technique is usually based on the physiological principles of diffusion, ultrafiltration, convection, and adsorption.

The key factors which drive Continuous Renal Replacement Therapy Market Growth are rise in the incidence of Acute Kidney Injury (AKI), increase in the incidence of sepsis and a surge in the adoption various key strategies by key players operating in market. In addition, rise in the demand of continuous renal replacement therapy worldwide is the major factor that boosts the growth of the market. For instance, according to the International Society of Nephrology (INR), in 2020 around 13.3 million people were estimated to have suffered from acute kidney injury. Furthermore, the rise in the geriatric population globally and increase in the prevalence of kidney-related diseases further boost the growth of the market. Furthermore, rise in technologically advanced CRRT products for pediatrics drives the growth of the market. For instance, in December, 2020, Medtronic plc. launched the pediatric dialysis emergency machine, named as Carpediem Cardio-Renal. This technology is indicated for use in patients who require hemofiltration or hemodialysis therapy due to acute renal fluid overload or damage. It is designed to give patients who weigh among 2.5 and 10 kilos continuous renal replacement therapy (CRRT).  However, high cost associated with CRRT devices in developing countries are the key factors likely to hamper the growth of the market. For instance, according to NCBI, it was estimated that the cost of continuous renal replacement therapy is around $389-600$ per day. In addition, the lack of awareness of continuous renal replacement therapy in developing countries like Brazil and South Africa due to inadequate funding, poor health care infrastructure, insufficient human resources, and geographic distance is the major factor hampering the growth of the market during the forecast period. In addition rise in government initiatives for regulatory approval will provide lucrative Continuous Renal Replacement Therapy Market Opportunity.

The global Continuous Renal Replacement Therapy Market Size was valued at $1.3 billion in 2021, and is projected to reach $2.6 billion by 2031, growing at a CAGR of 7.7% from 2022 to 2031.The continuous renal replacement therapy market is segmented on the basis of product, modality, age group, and region. Depending on product, the market is classified into dialysates and replacement fluids, disposables, and CRRT systems. Disposables segment is further categorized into hemofilters, bloodline sets and tubes, and other disposables. On the basis of modality, the market is classified into continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). According to age group, the market is segmented into pediatric, and adults. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

By Product Segment Review

By product, the dialysates and replacement fluids segment generated the highest revenue in the continuous renal replacement therapy market in 2021 owing to rise in the incidence of acute kidney injury which has increased the demand for CRRT. The Disposables segment is expected to witness considerable market growth during the forecast period, owing to the rise in the prevalence of kidney disorders along with rise in geriatric population.

By Modality Segment Review

By modality, the continuous venovenous hemofiltration (CVVH) segment generated highest Continuous Renal Replacement Therapy Market Share in the continuous renal replacement therapy market in 2021, as CVVH can remove large volumes of fluid while avoiding the hypotensive episodes caused by intermittent hemodialysis and its intermittent removal of large volumes of fluid which is creating demand. The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to witness considerable market growth during the forecast period. As CVVHD is an effective treatment in patients suffering from acute renal failure. Continuous veno-venous hemodialysis therapy has many technical advantages and is suitable for the geriatric population across the world are the key factor that drives the growth of the market.

By Age Group Segment Review

By age group, the adults segment generated the highest Continuous Renal Replacement Therapy Market Share  in 2021, owing to various regulatory approvals for the adult CRRT, and rise in development of novel products for CRRT. Along with this, adoption of various growth strategies by various market players are creating lucrative opportunities in the segment. The Pediatrics segment is expected to witness considerable market growth during the forecast period, owing to the rise in the prevalence of actue kidney disorders among pediatrics across the world.

By Region Segment Review

By region, Asia-Pacific accounted for the largest market share in Continuous Renal Replacement Therapy Industry in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in number of initiatives along with enhanced investments for the overall R&D of CRRT products. In addition, surge in focus of leading manufacturers on expanding their geographical presence in emerging.  North America is anticipated to witness lucrative growth. Due to high-unmet medical needs pertaining to the target disease segment, such as diabetes, hypertension, and chronic kidney disease, coupled with rising healthcare expenditure in the region are some key factors attributing to market growth.

The major companies profiled in Continuous Renal Replacement Therapy Industry include Anjue Medical Equipment Co. Ltd., Asahi Kasei Corporation, B. Braun Melsungen AG, Chongqing Shanwaishan Science and Technology Co. Ltd., Cytosorbents, Infomed SA, Medica S.p.A, Medical Components Inc., Medites Pharma spol. s.r.o., Medtronic plc., Nikkiso Co. Ltd., Ningbo Tianyi Medical Devices Co. Ltd., Nipro Corporation, SWS Hemodialysis Care Co. Ltd., Toray Industries Inc., Baxter International Inc., and Fresenius Medical Care AG & Co. KGaA

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the continuous renal replacement therapy market analysis from 2021 to 2031 to identify the prevailing continuous renal replacement therapy market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the continuous renal replacement therapy market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global continuous renal replacement therapy market trends, key players, market segments, application areas, and market growth strategies.

  Continuous Renal Replacement Therapy Market Report Highlights

Aspects	Details
By Product	Dialysates and Replacement Fluids Disposables Type Hemofilters Bloodline Sets & Tubes Other Disposables CRRT Systems
By Modality	Slow Continuous Ultrafiltration (SCUF) Continuous Venovenous Hemofiltration (CVVH) Continuous Venovenous Hemodiafiltration (CVVHDF) Continuous Venovenous Haemodialysis (CVVHD)
By Age Group	Adults Pediatrics
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest of LAMEA) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	SWS Hemodialysis Care, Chongqing Shanwaishan Science and Technology, B. Braun Melsungen Ag, Infomed SA, Fresenius Medical Care, Baxter International, Medtronic plc, Toray Industries Inc., Nipro Corporation, Asahi Kasei Corporation, Anjue Medical Equipment Co. Ltd, Ningbo Tianyi Medical Devices, Cytosorbents, Medica S.p.A, NIKKISO Co. Ltd, Medical Components Inc., Medites Pharma spol. s.r.o

Analyst Review

This section provides opinions of the CXOs of key companies operating in the continuous renal replacement therapy market. As per the CXOs, CRRT is expected to witness high adoption in the near future, owing to increase in number of kidney disorders across the world. In addition, the market is exhibiting high growth rate, owing to surge in awareness about use of CRRT.

In addition, rise in the demand for continuous renal replacement therapy worldwide is the major factor that boosts the growth of the market. However, lack of awareness and high cost associated with CRRT devices in developing countries are the key factors likely to hamper the growth of the market

By region, North America is expected to remain dominant during the forecast period, due to local presence of large in-house CRRT machines manufacturers like Baxter International Inc., and Medical Components, Inc. Moreover, Asia-Pacific registered highest CAGR and is expected to continue this trend throughout the forecast period, owing to improvement in healthcare facilities, rise in disposable income, surge in adoption of AKI awareness programs, and rapid improvement in economic conditions.

Author Name(s) : Vikita Thakur | Roshan Deshmukh

Related Tags

• Hemophilia
• Wound Care
• Pain Management
• Iv Bags